Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 14.97% is 15% below its 5-year average of 17.67%, around the middle of its 5-year range (-5.58%–33.21%).
38.63% above its 12-month average of 10.80%.
Reported quarterly profit margin; no daily interpolation. Q4 FY2026 (2026-06-30): 17.00%.
NET PROFIT MARGIN
14.97%
NET PROFIT MARGIN AVG TTM
10.80%
NET PROFIT MARGIN AVG 3Y
13.45%
NET PROFIT MARGIN AVG 5Y
17.67%
NET PROFIT MARGIN AVG 10Y
17.17%
NET PROFIT MARGIN AVG 15Y
21.19%
NET PROFIT MARGIN AVG 20Y
26.26%
CURRENT VS TTM AVG
+38.63%
CURRENT VS 3Y AVG
+11.28%
CURRENT VS 5Y AVG
-15.27%
CURRENT VS 10Y AVG
-12.81%
CURRENT VS 15Y AVG
-29.36%
CURRENT VS 20Y AVG
-43.00%
SECTOR MEDIAN · HEALTHCARE
9.21%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
+62.63%
vs the sector median at left
Bio-Techne Corporation
Market Cap
$11.37B
Net Profit Margin
14.97%
TTM Avg
10.80%
3Y Avg
13.45%
5Y Avg
17.67%
Market Cap
$10.83B
Net Profit Margin
8.42%
TTM Avg
7.89%
3Y Avg
6.46%
5Y Avg
6.98%
Market Cap
$10.80B
Net Profit Margin
13.46%
TTM Avg
9.62%
3Y Avg
9.77%
5Y Avg
24.94%
Market Cap
$12.08B
Net Profit Margin
-9.27%
TTM Avg
-7.30%
3Y Avg
-3.29%
5Y Avg
1.14%
Market Cap
$10.51B
Net Profit Margin
9.99%
TTM Avg
10.36%
3Y Avg
10.48%
5Y Avg
22.21%
Market Cap
$12.25B
Net Profit Margin
10.01%
TTM Avg
9.01%
3Y Avg
7.89%
5Y Avg
8.30%
Market Cap
$10.26B
Net Profit Margin
8.59%
TTM Avg
-21.22%
3Y Avg
-48.94%
5Y Avg
16.61%
Market Cap
$10.21B
Net Profit Margin
6.90%
TTM Avg
6.89%
3Y Avg
6.71%
5Y Avg
6.89%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bio-Techne Corporation (TECH) | $11.37B | 14.97% | 10.80% | 13.45% | 17.67% |
| DaVita Inc. (DVA)vs › | $11.46B | 6.05% | 6.39% | 5.83% | 6.41% |
| Universal Health Services, Inc. (UHS)vs › | $10.83B | 8.42% | 7.89% | 6.46% | 6.98% |
| The Cooper Companies, Inc. (COO)vs › | $10.80B | 13.46% | 9.62% | 9.77% | 24.94% |
| Baxter International Inc. (BAX)vs › | $12.08B | -9.27% | -7.30% | -3.29% | 1.14% |
| Align Technology, Inc. (ALGN)vs › | $10.51B | 9.99% | 10.36% | 10.48% | 22.21% |
| Encompass Health Corporation (EHC)vs › | $12.25B | 10.01% | 9.01% | 7.89% | 8.30% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $10.26B | 8.59% | -21.22% | -48.94% | 16.61% |
| The Ensign Group, Inc. (ENSG)vs › | $10.21B | 6.90% | 6.89% | 6.71% | 6.89% |
| Penumbra, Inc. (PEN)vs › | $12.56B | 10.67% | 6.92% | 5.54% | 3.35% |
Operating Margin
20.7%
Net Profit Margin
15.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 17.00% |
| 2026-03-31 | 16.40% |
| 2025-12-31 | 12.85% |
| 2025-09-30 | 13.33% |
| 2025-06-30 | -5.58% |
| 2025-03-31 | 7.14% |
| 2024-12-31 | 11.75% |
| 2024-09-30 | 11.61% |
| 2024-06-30 | 13.26% |
| 2024-03-31 | 16.17% |
| 2023-12-31 | 10.08% |
| 2023-09-30 | 18.41% |
| 2023-06-30 | 25.05% |
| 2023-03-31 | 23.87% |
| 2022-12-31 | 18.41% |
| 2022-09-30 | 33.21% |
| 2022-06-30 | 21.35% |
| 2022-03-31 | 20.92% |
| 2021-12-31 | 29.77% |
| 2021-09-30 | 27.01% |
| 2021-06-30 | 5.78% |
| 2021-03-31 | 18.80% |
| 2020-12-31 | 20.63% |
| 2020-09-30 | 16.35% |
| 2020-06-30 | 33.47% |
| 2020-03-31 | 18.71% |
| 2019-12-31 | 64.68% |
| 2019-09-30 | 7.86% |
| 2019-06-30 | 8.59% |
| 2019-03-31 | 24.16% |
| 2018-12-31 | 10.06% |
| 2018-09-30 | 10.68% |
| 2018-06-30 | 22.69% |
| 2018-03-31 | 12.04% |
| 2017-12-31 | 31.69% |
| 2017-09-30 | 10.97% |
| 2017-06-30 | 18.40% |
| 2017-03-31 | 14.85% |
| 2016-12-31 | 4.79% |
| 2016-09-30 | 12.47% |
| 2016-06-30 | 19.02% |
| 2016-03-31 | 23.13% |
| 2015-12-31 | 21.38% |
| 2015-09-30 | 20.21% |
| 2015-06-30 | 22.38% |
| 2015-03-31 | 21.28% |
| 2014-12-31 | 29.66% |
| 2014-09-30 | 22.04% |
| 2014-06-30 | 28.99% |
| 2014-03-31 | 33.11% |
| 2013-12-31 | 29.82% |
| 2013-09-30 | 32.02% |
| 2013-06-30 | 35.75% |
| 2013-03-31 | 40.89% |
| 2012-12-31 | 33.78% |
| 2012-09-30 | 34.21% |
| 2012-06-30 | 34.62% |
| 2012-03-31 | 37.98% |
| 2011-12-31 | 34.57% |
| 2011-09-30 | 35.47% |
| 2011-06-30 | 36.30% |
| 2011-03-31 | 40.73% |
| 2010-12-31 | 39.19% |
| 2010-09-30 | 38.82% |
| 2010-06-30 | 38.81% |
| 2010-03-31 | 46.09% |
| 2009-12-31 | 37.73% |
| 2009-09-30 | 40.24% |
| 2009-06-30 | 39.12% |
| 2009-03-31 | 40.73% |
| 2008-12-31 | 38.18% |
| 2008-09-30 | 41.25% |
| 2008-06-30 | 40.22% |
| 2008-03-31 | 42.56% |
| 2007-12-31 | 38.04% |
| 2007-09-30 | 39.79% |
| 2007-06-30 | 39.24% |
| 2007-03-31 | 39.69% |
| 2006-12-31 | 35.54% |
| 2006-09-30 | 37.50% |
| 2006-06-30 | 37.43% |
| 2006-03-31 | 37.12% |
| 2005-12-31 | 34.38% |
| 2005-09-30 | 35.63% |
| 2005-06-30 | 39.05% |
| 2005-03-31 | 38.47% |
| 2004-12-31 | 35.35% |
| 2004-09-30 | 34.68% |
| 2004-06-30 | 31.48% |
| 2004-03-31 | 34.36% |
| 2003-12-31 | 32.33% |
| 2003-09-30 | 33.09% |
| 2003-06-30 | 32.15% |
| 2003-03-31 | 32.84% |
| 2002-12-31 | 29.67% |
| 2002-09-30 | 30.23% |
